HomeAI · summaries
Storia in 4 fonti
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
Confronto fonti
4 prospettive sulla stessa storiaTimeline cronologica
- ·
morningstar.com
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
First Dual GLP-1/GIP Receptor Agonist Developed for Type 1 Diabetes Shows Promising Benefits in Blood Glucose Control
- ·
healio.com
Once-daily GLP-1/GIP dual agonist lowers HbA1c, weight in type 1 diabetes
NEW ORLEANS — A once-daily GLP-1/GIP dual agonist reduced HbA1c and body weight at 16 weeks among adults with type 1 diabetes, according to findings from a phase 2 trial presented…
- ·
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
Ultra-Long-Acting Injectable GLP-1 RA Shows Promise for Supporting Weight Management in Individuals With and Without Type 2 Diabetes
- ·
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
Breakthrough Studies Demonstrate Effectiveness of the First Triple-Hormone Therapy for Type 2 Diabetes and Obesity
- ·
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
Once-Weekly Drug Demonstrates Promising Dual Benefits in Obesity and Metabolic Health
- ·
Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
Once-Weekly CagriSema (Amylin-Semaglutide) Combination Injection More Effective than Standalone Medications
- ·
Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1
Diabetology’s Breakthrough Clinical Data From Oraglutide™ Oral GLP-1
- ·
medpagetoday.com
Monthly GLP-1 for Obesity Promising as More Manageable Alternative
Less frequent dosing could support better long-term adherence, says researcher
- ·
Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results
Novel Once-Daily Pill Delivers Positive Blood Glucose and Weight Reduction Results
- ·
statnews.com
AstraZeneca’s GLP-1 pill shows promise in obesity, diabetes trials
AstraZeneca’s GLP-1 pill showed promise in mid-stage obesity and diabetes studies, but it may still be too early to determine how it stacks up against other oral treatments.